Question 1

What is Mycophenolate mofetil?

Accepted Answer

Mycophenolate mofetil belongs to a class of medications known as immunosuppressive agents . It works by inhibiting the growth and activity of specific white blood cells that are part of the body's immune response.

By lowering these natural defenses, the medication helps the body accept a new organ. It is generally used as part of a long-term strategy to manage the body's immune system activity.

Question 2

What is Mycophenolate mofetil used for?

Accepted Answer

Mycophenolate mofetil is used to treat:

Prophylaxis of organ rejection in kidney transplant

Prophylaxis of organ rejection in heart transplant

Prophylaxis of organ rejection in liver transplant

Question 3

How does Mycophenolate mofetil work?

Accepted Answer

Preventing Organ Rejection

The immune system is the body's natural defense against foreign invaders, such as bacteria and viruses. When a person receives a transplanted organ, like a kidney, heart, or liver, the immune system may identify the new organ as foreign and try to attack it. This reaction is called organ rejection.

Targeting Immune Cells

Mycophenolate mofetil works by suppressing the activity of the immune system. Specifically, it interferes with the body's ability to produce certain types of white blood cells called lymphocytes. These cells are primarily responsible for recognizing and attacking foreign tissue.

By limiting the production and growth of these cells, the medication helps the body accept the new organ. This process involves:

Reducing the immune system's response to the transplanted tissue.

Lowering the risk of the body attacking the new organ.

Helping the transplanted organ continue to function as intended.

Question 4

What are the brand names for Mycophenolate mofetil?

Accepted Answer

Mycophenolate mofetil is sold under the brand names CellCept and Myfortic .

Question 5

What are the active ingredients in Mycophenolate mofetil?

Accepted Answer

The active ingredient in Mycophenolate mofetil is mycophenolate mofetil .

Question 6

What are the side effects of Mycophenolate mofetil?

Accepted Answer

Common side effects of Mycophenolate mofetil may include:

diarrhea

nausea

vomiting

and others.

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is Mycophenolate mofetil?

Accepted Answer

Mycophenolate mofetil belongs to the immunosuppressant drug class.

Question 8

What is the dosage of Mycophenolate mofetil and how do I take it?

Accepted Answer

How to Take

Mycophenolate mofetil is available as capsules, tablets, and a liquid suspension to be taken by mouth. It is also administered as an injection into a vein. Oral doses are usually taken twice a day on a consistent schedule, typically 12 hours apart.

It is generally recommended to take this medication on an empty stomach, at least one hour before or two hours after meals. However, you should follow your healthcare provider's specific instructions and remain consistent in how you take it relative to food intake.

Swallow tablets and capsules whole. Do not crush, chew, or break them.

If using the liquid form, shake the bottle well before measuring each dose with the provided oral syringe or measuring device.

Try to take your doses at the same time every day to maintain a steady level of medication in your body.

Handling the Medication

Special care should be taken when handling this drug. Do not open capsules or touch broken tablets. If the powder from a capsule or the liquid suspension gets on your skin, wash the area immediately with soap and water. If it gets in your eyes, rinse them thoroughly with plain water.

Missed Dose

If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and return to your regular timing. Do not take extra medication to make up for a missed dose.

Question 9

Is Mycophenolate mofetil safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy Risks

Mycophenolate mofetil can cause serious harm to an unborn baby. Taking this medication during pregnancy significantly increases the risk of miscarriage, particularly during the first trimester. It also carries a high risk of birth defects, which may affect the development of the ears, face, heart, and other organs.

Prevention and Planning

Because of these risks, healthcare providers require specific precautions for individuals who can become pregnant:

Pregnancy tests are typically required before starting treatment and at regular intervals during therapy.

Effective birth control must be used before starting the medication, throughout the entire treatment period, and for at least six weeks after the last dose.

Patients are often required to participate in a restricted distribution program (REMS) to ensure they understand the risks and follow safety protocols.

Men taking mycophenolate mofetil should also use effective contraception, such as condoms, during treatment and for at least 90 days after their final dose to prevent pregnancy in their partners.

Breastfeeding

It is not currently known if mycophenolate mofetil passes into human breast milk. Due to the potential for serious side effects in a nursing child, experts generally advise against breastfeeding while using this medication. Patients should discuss feeding options and potential risks with their healthcare provider before starting treatment.

Question 10

What forms and strengths does Mycophenolate mofetil come in?

Accepted Answer

Oral Formulations

Mycophenolate mofetil is commonly administered by mouth in the following forms:

Capsules

Tablets

Oral suspension (a liquid form)

Injectable Formulations

For patients who cannot take medication by mouth, mycophenolate mofetil is available as a:

Powder for injection (reconstituted and administered as an intravenous infusion by a healthcare professional)

Question 11

What is the FDA approval status of Mycophenolate mofetil?

Accepted Answer

FDA Approval and Indications

Mycophenolate mofetil is approved by the U.S. Food and Drug Administration (FDA) to prevent organ rejection in patients receiving kidney, heart, or liver transplants. It is typically used in combination with other medications, such as corticosteroids and cyclosporine.

Boxed Warning

The FDA requires a boxed warning for mycophenolate mofetil due to several significant safety concerns:

Pregnancy Risks: Use during pregnancy is associated with an increased risk of first-trimester pregnancy loss (miscarriage) and serious congenital malformations (birth defects).

Serious Infections: Patients are at an increased risk of developing serious bacterial, viral, fungal, and protozoal infections, including opportunistic infections that may be fatal.

Malignancies: There is an increased risk of developing lymphomas and other malignancies, particularly of the skin.

Risk Evaluation and Mitigation Strategy (REMS)

Because of the risks of birth defects and miscarriage, the FDA has implemented a single shared Risk Evaluation and Mitigation Strategy (REMS) for all mycophenolate products. The Mycophenolate REMS program is designed to ensure that healthcare providers and patients are fully informed about these risks. It requires providers to counsel patients on the need for effective contraception and regular pregnancy testing before and during treatment.

Question 12

What should I know about Mycophenolate mofetil and pregnancy?

Accepted Answer

Pregnancy Risks

Mycophenolate mofetil can cause serious harm to an unborn baby. There is a high risk of miscarriage (pregnancy loss), particularly during the first trimester. Additionally, infants exposed to this medication in the womb have a significant risk of being born with structural birth defects.

Common Birth Defects

External ear abnormalities

Cleft lip and cleft palate

Heart defects

Abnormalities of the limbs, kidneys, or esophagus

Safety Program and Testing

Because of these risks, the medication is only available through a restricted program called the Mycophenolate Risk Evaluation and Mitigation Strategy (REMS). Before starting treatment, women who can become pregnant must have a negative pregnancy test. Regular pregnancy testing is also required during treatment.

Contraception Requirements

Women of childbearing potential must use acceptable forms of birth control beginning four weeks before starting the medication, throughout the entire treatment period, and for at least six weeks after the final dose. Men with female partners who can become pregnant should use condoms during treatment and for at least 90 days after stopping the medication.

Breastfeeding

It is not known if mycophenolate mofetil passes into human breast milk. Due to the potential for serious side effects in a nursing infant, breastfeeding is generally not recommended while using this medication.

Mycophenolate mofetil

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Brand Names

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Pregnancy Information

FAQ

Additional Resources

Support & Help Resources

Found an Error?